1600014K23Rik Inhibitors
Chemical inhibitors of 1600014K23Rik encompass a range of compounds that can interfere with specific signaling pathways, ultimately leading to the inhibition of this protein's activity. Wortmannin and LY294002 are both inhibitors of phosphoinositide 3-kinase (PI3K), which is pivotal in various cellular functions. By inhibiting PI3K, these chemicals can prevent the phosphorylation and activation of downstream proteins, including 1600014K23Rik, thereby blocking its activity. Similarly, Rapamycin targets mTOR, another key protein in cellular growth and proliferation signaling pathways. By inhibiting mTOR, Rapamycin can suppress the cascade of events that activate proteins like 1600014K23Rik. SB203580 takes a different approach by selectively inhibiting p38 MAP kinase, which, if part of the signaling pathway involving 1600014K23Rik, would result in decreased activation of this protein.
Further in the array of chemical inhibitors, PD98059 and U0126 both act as specific inhibitors of MEK, another kinase in the MAP kinase pathway. By preventing MEK from activating its downstream targets, which may include 1600014K23Rik, these inhibitors can suppress the protein's activity. SP600125, as an inhibitor of JNK, functions in a similar manner by blocking the signaling processes required for the function of subsequent proteins in the cascade. PP2 and Dasatinib are inhibitors of tyrosine kinases, with Dasatinib having a broader spectrum. These inhibitors block phosphorylation events that are crucial for subsequent protein activation, including the potential activation of 1600014K23Rik. MK-2206, as an allosteric inhibitor of AKT, disrupts the activity of downstream proteins that are crucial for various cellular processes. Bisindolylmaleimide I specifically inhibits protein kinase C (PKC), and Staurosporine is a broad-spectrum protein kinase inhibitor. By targeting PKC and a wide range of other kinases, these compounds can prevent the activation of proteins that are regulated by these kinases, such as 1600014K23Rik, leading to a decrease in its activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent phosphoinositide 3-kinase (PI3K) inhibitor. Since PI3K is involved in many signaling pathways including those regulating cell growth and survival, the inhibition of PI3K by Wortmannin could lead to a decrease in the activity of 1600014K23Rik, assuming 1600014K23Rik is a downstream effector in the PI3K pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is another PI3K inhibitor, functioning similarly to Wortmannin. By inhibiting PI3K, LY294002 can suppress the phosphorylation of downstream targets, potentially including 1600014K23Rik, thereby inhibiting its function. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that can disrupt the mTOR signaling pathway, which is involved in cell growth and proliferation. Through the inhibition of mTOR, Rapamycin could inhibit downstream proteins that are regulated by this pathway, including possibly 1600014K23Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 MAP kinase. If 1600014K23Rik acts downstream of p38 MAP kinase in a signaling cascade, then inhibition by SB203580 could result in diminished activity of 1600014K23Rik. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 specifically inhibits MEK, which is upstream of ERK in the MAP kinase pathway. Inhibition of MEK by PD98059 would prevent the activation of ERK and potentially inhibit downstream targets, potentially including 1600014K23Rik. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is also a MEK inhibitor that functions similarly to PD98059, and through the inhibition of MEK, it can disrupt the activation of downstream proteins within the MAP kinase pathway that could include 1600014K23Rik. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, and by inhibiting JNK activity, it can block the signaling that might be required for the function of downstream proteins including 1600014K23Rik. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Src kinases can phosphorylate a variety of downstream substrates, and PP2 could inhibit these phosphorylation events, potentially affecting the activity of 1600014K23Rik. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib broadly inhibits tyrosine kinases, including Src family kinases. By inhibiting these kinases, Dasatinib could prevent phosphorylation of substrates downstream in the signaling pathway, which may include 1600014K23Rik. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
MK-2206 is an allosteric inhibitor of AKT, a serine/threonine-specific protein kinase that plays a key role in multiple cellular processes. Inhibition of AKT by MK-2206 could lead to reduced activity of downstream proteins, potentially including 1600014K23Rik. | ||||||